Tsun JG, Shiu SW, Wong Y, Yung S, Chan TM, Tan KC
By activating GLP-1 receptors, retatrutide is thought to promote insulin secretion, reduce appetite, and slow gastric emptying effects that collectively contribute to improved blood glucose control and reductions in body weight
BPC 157 Safety BPC 157 is well tolerated
Similarly, Eric Polley, PhD, a UChicago data science and public health expert, recently led a study published in Nature Cardiovascular Research that used statistical modeling to emulate a clinical trial comparing the effects of four different classes of diabetes medication in patients with moderate cardiovascular risk
The epidemic scale of diabetes and obesity, and their links to cardiovascular and kidney disease, created demand for more effective incretin-based therapies